Chiral Molecule-mediated Porous Cu xO Nanoparticle Clusters with Antioxidation Activity for Ameliorating Parkinson's Disease

J Am Chem Soc. 2019 Jan 16;141(2):1091-1099. doi: 10.1021/jacs.8b11856. Epub 2018 Dec 28.

Abstract

Reactive oxygen species (ROS)-mediated mitochondrial dysfunction is one of the major pathological mechanisms of Parkinson's disease. Using inorganic nanomaterials to scavenge ROS has drawn significant interest and can prevent ROS-mediated neurological disorders. We prepared uniform Cu xO nanoparticle clusters (NCs) with an average size of 65 ± 7 nm, using phenylalanine (Phe) as the structure-directing agent. These Cu xO NCs functionally mimicked the activities of peroxidase, superoxide dismutase, catalase, and glutathione peroxidase. Because they eliminated ROS, the Cu xO NCs inhibited neurotoxicity in a cellular model of Parkinson's disease and rescued the memory loss of mice with Parkinson's disease. The biocompatibility and multiple enzyme-mimicking activities of Cu xO NCs offer new opportunities for the application of NCs in biomedicine, biosensing, and biocatalysis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Animals
  • Antiparkinson Agents / chemical synthesis
  • Antiparkinson Agents / therapeutic use*
  • Brain / pathology
  • Catalysis
  • Cell Line, Tumor
  • Copper / chemistry
  • Copper / therapeutic use*
  • Free Radical Scavengers / chemical synthesis
  • Free Radical Scavengers / therapeutic use*
  • Humans
  • Maze Learning / drug effects
  • Memory / drug effects
  • Metal Nanoparticles / chemistry
  • Metal Nanoparticles / therapeutic use*
  • Mice
  • NIH 3T3 Cells
  • Nootropic Agents / chemical synthesis
  • Nootropic Agents / therapeutic use
  • Oxidative Stress / drug effects
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / pathology
  • Reactive Oxygen Species / metabolism

Substances

  • Antiparkinson Agents
  • Free Radical Scavengers
  • Nootropic Agents
  • Reactive Oxygen Species
  • Copper